Renovo News

  • Juvista EU Phase 3 trial results
    11th Febrero 2011
    Renovo announces the results of the Juvista EU Phase 3 trial....read more
  • Results of AGM
    8th Febrero 2011
    Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs to reduce scarring, improve wound healing and enhance tissue regeneration, announces that at its Annual General Meeting (AGM) held today all resolutions were duly passed....read more
  • Interim Management Statement
    8th Febrero 2011
    In advance of today's AGM we release our Interim Management Statement for the period to 31 December 2010....read more
  • Notice of AGM
    7th Enero 2011
    We confirm we have posted the Notice of Annual General Meeting to shareholders - details of the associated RNS may be viewed ...read more
  • Juvista trial results
    30th Noviembre 2010
    ...read more
  • Notice of Results
    9th Noviembre 2010
    We shall announce our Preliminary results on 14 December 2010 - the full RNS making this announcement may be viewed ...read more
  • Proactive Investors Renovo StockTube Interview
    9th Septiembre 2010
    Proactive Investors Renovo StockTube Interview: “Mark Ferguson, CEO of Renovo, explains why there is little downside risk to investing in his company and why he expects shares to rise significant...read more